M&T Bank Corp Novavax Inc Transaction History

M&T Bank Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $152,429 - $312,379	-2,186 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$134.56 - $217.97 $8,073 - $13,078	60 Added 2.82%	2,186 $312,000
Q3 2021 Oct 28, 2021	BUY	$177.8 - $270.58 $31,648 - $48,163	178 Added 9.14%	2,126 $441,000
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $184,041 - $391,916	-1,521 Reduced 43.85%	1,948 $414,000
Q1 2021 May 06, 2021	SELL	$112.98 - $319.93 $140,773 - $398,632	-1,246 Reduced 26.43%	3,469 $629,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $78 - $139	-1 Reduced 0.02%	4,715 $526,000
Q3 2020 Nov 06, 2020	SELL	$79.44 - $178.51 $3,018 - $6,783	-38 Reduced 0.8%	4,716 $511,000
Q2 2020 Jul 29, 2020	BUY	$13.86 - $83.61 $65,890 - $397,481	4,754 New	4,754 $396,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.